Detalhe da pesquisa
1.
Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Cancer Immunol Immunother
; 68(12): 1979-1993, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31686124
2.
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.
Haematologica
; 102(5): 932-940, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126963
3.
The signature of a T-cell response to KSHV persists across space and time in individuals with epidemic and endemic KS from Uganda.
bioRxiv
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370623
4.
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer.
Sci Rep
; 14(1): 345, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172168
5.
Serial Analysis of the T-Cell Receptor ß-Chain Repertoire in People Living With HIV Reveals Incomplete Recovery After Long-Term Antiretroviral Therapy.
Front Immunol
; 13: 879190, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585986
6.
Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes.
Front Oncol
; 12: 952252, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185254
7.
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer.
Front Immunol
; 13: 961105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159875
8.
A Pilot Study of Atezolizumab Plus Hypofractionated Image Guided Radiation Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 108(1): 170-177, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756415
9.
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.
Clin Cancer Res
; 24(15): 3519-3527, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716921
10.
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis.
Blood Adv
; 1(9): 535-544, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296973
11.
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.
JCI Insight
; 1(5)2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213183
12.
Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma.
Blood Cancer J
; 9(10): 77, 2019 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570697
13.
Capacity building for hematologic malignancies in Uganda: a comprehensive research, training, and care program through the Uganda Cancer Institute-Fred Hutchinson Cancer Research Center collaboration.
Blood Adv
; 2(Suppl 1): 8-10, 2018 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504187
14.
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice.
PLoS One
; 8(11): e79874, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24278200
15.
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.
J Immunother
; 35(2): 131-41, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22306901
16.
High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma.
Blood Adv
; 1(16): 1261-1262, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296767